Literature DB >> 9201837

Allograft bone use during instrumentation and fusion in the treatment of adolescent idiopathic scoliosis.

J S Blanco1, C J Sears.   

Abstract

STUDY
DESIGN: In a retrospective study, 25 patients undergoing posterior spine fusion with allograft bone and Cotrel-Dubousset Instrumentation were assessed regarding the efficacy of allograft bone use.
OBJECTIVES: To determine if allograft bone use had deleterious effects regarding fusion rates and maintenance of deformity correction. SUMMARY OF BACKGROUND DATA: Previous studies using allograft bone in adult lumbar spine fusion models have consistently shown poor fusion rates. Studies in the pediatric population have been more favorable but in idiopathic cases have used cast or brace immobilization with Harrington instrumentation.
METHODS: Twenty-five skeletally immature patients with is average age of 14 +/- 4 years and an average follow-up of 4 +/- 2 years (minimum of 3 years) were evaluated with anteroposterior, lateral, and oblique radiographs to assess the fusion mass.
RESULTS: Preoperative curves averaged 55.5 degrees and immediate correction averaged 58% with an average postoperative curve of 23.2 degrees. Loss of correction at final follow-up was 3.7 degrees. No pseudarthroses were identified clinically or radiographically.
CONCLUSIONS: Allograft bone use in the pediatric patient with idiopathic scoliosis undergoing rigid segmental instrumentation dependably results in fusion with good maintenance of correction.

Entities:  

Mesh:

Year:  1997        PMID: 9201837     DOI: 10.1097/00007632-199706150-00011

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  8 in total

1.  Healing properties of allograft from alendronate-treated animal in lumbar spine interbody cage fusion.

Authors:  Qingyun Xue; Haisheng Li; Xuenong Zou; Mathias Bünger; Niels Egund; Martin Lind; Finn Bjarke Christensen; Cody Bünger
Journal:  Eur Spine J       Date:  2004-07-10       Impact factor: 3.134

2.  Evaluating post-operative pain management at the iliac crest bone graft site: an editorial.

Authors:  Uzondu F Agochukwu; John G DeVine
Journal:  J Spine Surg       Date:  2016-09

3.  Clinical and radiographic outcomes of the treatment of adolescent idiopathic scoliosis with segmental pedicle screws and combined local autograft and allograft bone for spinal fusion: a retrospective case series.

Authors:  Xiaoming Yang; Hongguang Xu; Ming Li; Suxi Gu; Xiutong Fang; Jingjie Wang; Jianqiang Ni; Dajiang Wu
Journal:  BMC Musculoskelet Disord       Date:  2010-07-14       Impact factor: 2.362

4.  Autogenous iliac crest bone graft versus banked allograft bone in scoliosis surgery in patients with Duchenne muscular dystrophy.

Authors:  Toshiyuki Nakazawa; Masashi Takaso; Takayuki Imura; Kou Adachi; Kensuke Fukushima; Wataru Saito; Gennyo Miyajima; Atsushi Minatani; Ryousuke Shinntani; Moritoshi Itoman; Kazuhisa Takahashi; Masashi Yamazaki; Seiji Ohtori; Atsushi Sasaki
Journal:  Int Orthop       Date:  2009-06-16       Impact factor: 3.075

5.  Comparison between harvesting and preserving the spinous process for adolescent idiopathic scoliosis.

Authors:  Yu-Cheng Yeh; Chi-Chien Niu; Lih-Huei Chen; Wen-Jer Chen; Po-Liang Lai
Journal:  BMC Musculoskelet Disord       Date:  2016-08-24       Impact factor: 2.362

Review 6.  Bone Graft Options for Spine Fusion in Adolescent Patients with Idiopathic Scoliosis.

Authors:  Xi-Ming Xu; Gong Zhang; Fei Wang; Xian-Zhao Wei; Ming Li
Journal:  Chin Med J (Engl)       Date:  2016-01-05       Impact factor: 2.628

7.  Quantitative analysis of local bone graft harvested from the posterior elements during posterior spinal fusion in Adolescent Idiopathic Scoliosis patients.

Authors:  Qi Qi Choo; Chee Kidd Chiu; Kulathunga Arachchige Lisitha; Chris Yin Wei Chan; Mun Keong Kwan
Journal:  J Orthop       Date:  2018-12-21

8.  Current concepts and controversies on adolescent idiopathic scoliosis: Part I.

Authors:  Alok Sud; Athanasios I Tsirikos
Journal:  Indian J Orthop       Date:  2013-03       Impact factor: 1.251

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.